MLP Saglik Hizmetleri (MPARK) Q3 2026 earnings summary

Executive summary

• 9M revenue rose 6.6% to TL54.217bn; EBITDA increased 19.5% to TL16.2bn, with margin expanding 324 bps to 29.9%.

• 9M net profit attributable to parent equity holders increased 5.1% to TL5.554bn; total net profit was TL5.814bn versus TL5.844bn.

• Net debt/EBITDA improved to 0.7x from 0.8x in 2025; 9M free cash flow turned positive at TL776m.

Financial highlights

• Q3 revenue was TL18.189bn, up 7.3% YoY; Q3 EBITDA rose 10.2% to TL5.7bn, with a 31.3% margin.

• 9M EBIT declined 15.3% to TL8.67bn and its margin fell 413 bps to 16.0%; operating profit was TL8.821bn versus TL9.704bn.

• 9M net profit before tax was TL7.261bn versus TL8.285bn; net monetary position gain was TL3.234bn versus TL2.191bn.

• Basic EPS was TL29.07 versus TL27.68; weighted average shares were 191.012m in both periods.

Outlook and guidance

• Planned openings: Medical Park Çanakkale in Q4 2026, 80 beds; Liv Hospital Bursa in Q1 2027, 150 beds.

• Further planned openings: Liv Hospital Ankara in Q4 2027–Q1 2028, 185 beds; Liv Hospital Ataşehir in Q3–Q4 2028, 200 beds.